Skip to main content

Table 2 Clinical and biological characteristics according to the Gensini score tertiles and degree of CAD

From: Relationship between TyG index and the degree of coronary artery lesions in patients with H-type hypertension

Variable

Gensini score tertiles

Degree of CAD

Lowest tertile ≤ 32 (n = 114)

Mid tertile 32 ~ 53 (n = 100)

Highest tertile ≥ 53 (n = 106)

p value

Non-severe stenosis (n = 214)

Sever stenosis (n = 106)

p value

TyG index

8.47 ± 0.51

8.94 ± 0.69

9.48 ± 0.86

 < 0.001

8.7 ± 0.6

9.5 ± 0.9

 < 0.001

Age, years

65.0 ± 10.6

67.0 ± 10.0

65.8 ± 10.3

0.165

67.3 ± 10.3

65.7 ± 10.6

0.181

Male

53 (46.5)

54 (54.0)

55 (51.9)

0.521

107 (50.0)

55 (51.9)

0.751

BMI, kg/m2

23.1 ± 3.1

24.4 ± 3.6

24.3 ± 2.7

0.005

23.7 ± 3.4

24.3 ± 2.7

0.136

SBP, mmHg

141.2 ± 28.0

138.2 ± 20.1

139.8 ± 20.4

0.784

139.8 ± 24.6

139.8 ± 20.4

0.998

DBP, mmHg

81.6 ± 15.4

82.5 ± 11.8

81.4 ± 11.4

0.567

82.0 ± 13.8

81.4 ± 11.4

0.698

Heart rate, bpm

75.5 ± 15.0

77.0 ± 13.2

77.3 ± 13.9

0.536

76.2 ± 14.2

77.3 ± 13.9

0.521

Smoker

9 (7.9)

30 (30.0)

49 (46.2)

 < 0.001

39 (18.2)

49 (46.2)

 < 0.001

Drinker

2 (1.8)

7 (7.0)

19 (17.9)

 < 0.001

9 (4.2)

19 (17.9)

 < 0.001

H-type hypertension

34 (29.8)

53 (53.0)

67 (63.2)

 < 0.001

87 (40.7)

67 (63.2)

 < 0.001

METS-IR index

34.2 ± 6.0

38.5 ± 7.9

41.3 ± 8.1

0.067

36.2 ± 7.3

41.3 ± 8.1

 < 0.001

Metabolic syndrome

2 (1.8)

6 (6.0)

38 (35.8)

 < 0.001

8 (3.7)

38 (35.8)

 < 0.001

Diabetes mellitus

20 (17.5)

33 (33.0)

42 (39.6)

0.001

53 (24.8)

42 (39.6)

0.006

Biochemical indicators

 WBC, 109/L

6.0 ± 2.0

6.5 ± 2.0

6.6 ± 2.2

0.065

6.3 ± 2.0

6.6 ± 2.2

0.130

 Neutrophil ratio, %

65.8 ± 10.8

66.5 ± 9.6

66.3 ± 10.2

0.819

66.1 ± 10.2

66.6 ± 10.1

0.702

 Platelet, 109/L

211.2 ± 62.2

225.7 ± 65.9

211.3 ± 55.4

0.153

218.0 ± 64.2

211.3 ± 55.4

0.357

 Albumin, g/L

41.6 ± 3.7

41.9 ± 3.6

41.6 ± 4.1

0.083

41.8 ± 3.7

41.6 ± 4.1

0.646

 Homocysteine

16.4 ± 8.4

18.4 ± 8.1

17.8 ± 6.0

 < 0.001

17.3 ± 8.3

17.8 ± 6.0

0.078

 FPG,mg/dl

111.2 ± 29.3

140.4 ± 64.5

168.7 ± 82.2

 < 0.001

124.8 ± 51.1

168.7 ± 82.2

 < 0.001

 TC, mg/dl

155.7 ± 42.8

158.5 ± 44.7

170.2 ± 51.1

0.051

157.0 ± 43.6

170.2 ± 51.1

0.017

 TG, mg/dl

98.3 ± 47.8

1138.3 ± 87.2

219.0 ± 246.8

 < 0.001

117.0 ± 71.7

219.0 ± 246.8

 < 0.001

 HDL-C, mg/dl

52.7 ± 15.0

47.5 ± 12.8

42.6 ± 13.7

 < 0.001

50.3 ± 14.2

42.6 ± 13.7

 < 0.001

 LDL-C, mg/dl

83.3 ± 33.5

86.0 ± 36.4

95.2 ± 40.3

0.047

84.6 ± 34.8

95.2 ± 40.3

0.016

 Uric acid, mg/dl

6.2 ± 1.8

6.3 ± 2.1

6.8 ± 1.8

0.047

6.2 ± 2.0

6.8 ± 1.8

0.015

 SCr, umol/L

85.4 ± 49.9

77.7 ± 37.6

82.4 ± 37.7

0.064

81.8 ± 44.7

82.4 ± 37.7

0.908

Coronary angiography

 Lesion vessels

0.6 ± 1.0

1.1 ± 1.1

1.7 ± 1.2

 < 0.001

   

 Three-vessel disease

28(24.6)

47(47.0)

75(70.8)

 < 0.001

   

 Gensini score, (IQR)

23.5 ± 4.3

41.9 ± 5.8

88.5 ± 34.1

 < 0.001

   

Medication, n (%)

 Antiplatelet

23 (20.2)

18 (18.0)

25 (23.6)

0.606

41 (19.2)

25 (23.6)

0.357

 Statin

10 (8.8)

10(10.0)

11 (104)

0.915

20 (9.3)

11 (10.4)

0.769

 CCB

25 (21.9)

20 (20.0)

14 (13.2)

0.221

45 (21.0)

14 (13.2)

0.090

 Beta blockers

11 (9.6)

7 (7.0)

13 (12.3)

0.443

18 (8.4)

13 (12.3)

0.273

 ACEI/ARB

17 (14.9)

5 (5.0)

1 (0.9)

 < 0.001

22 (10.3)

1 (0.9)

0.002

  1. Data are presented as the IQR, mean ± SD or n (%)
  2. BMI body mass index, SBP systolic blood pressure, DBP diastolic blood pressure, IQR interquartile range, hs-CRP hypersensitive C-reactive protein, WBC white blood cell, FPG fasting plasma glucose, TC total cholesterol, TG Triglycerides, HDL-C high-density lipoprotein cholesterol, LDL-C low-density lipoprotein cholesterol, SCr Serum creatinine concentration, CCB calcium channel blocker, ACEI, angiotensin-converting enzyme inhibitor, ARB angiotensin receptor blocker